CIK 0001131343 · Non-accelerated filer
ALTERITY THERAPEUTICS LTD
Sign in to watch- Ticker
- PRNAF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- Australia
- Entity type
- other
- Phone
- 61 3 9349 4906
- Business address
- LEVEL 15, 500 COLLINS STREET, MELBOURNE, Australia, VIC 3000
- Former names
- PRANA BIOTECHNOLOGY LTD
Securities
- ATHE American Depositary Shares Nasdaq
- PRNAF Common stock OTC
- Open-market buys, last 90 days
- $23,810
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$23,810. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-31 | Stamler David Allen Chief Executive Officer | Purchase · Listed option exp 31 Aug 2026 | −47,620 | $0.50 | $24K | 0 |
| 2026-08-31 | Marks Peter Ashley Director | Purchase | +47,620 | $0.50 | $24K | 191,340 |
| 2026-08-31 | Marks Peter Ashley Director | Purchase · Listed option exp 31 Aug 2026 | −47,620 | $0.50 | $24K | 0 |
| 2026-06-15 | Babarczy Julian Michael Director | Grant or award · Unlisted option exp 15 Jun 2031 | +2,000,000 | 2,000,000 | ||
| 2026-06-15 | Gozlan Lawrence Bernard Director | Grant or award · Listed option exp 15 Jun 2031 | +1,000,000 | 1,000,000 |
Page 1 of 1 · 5 trades